AAAAAA
Results: 1-25/41
Authors:
Kammen, BF
Matthay, KK
Pacharn, P
Gerbing, R
Brasch, RC
Gooding, CA
Citation: Bf. Kammen et al., Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis, AM J ROENTG, 176(3), 2001, pp. 755-759
Authors:
Bertucio, GS
Wara, WM
Matthay, KK
Ablin, AR
Johnston, JO
O'Donnell, RJ
Weinberg, V
Haas-Kogan, DA
Citation: Gs. Bertucio et al., Functional and clinical outcomes of limb-sparing therapy for pediatric extremity sarcomas, INT J RAD O, 49(3), 2001, pp. 763-769
Authors:
Tang, HR
Da Silva, AJ
Matthay, KK
Price, DC
Huberty, JP
Hawkins, RA
Hasegawa, BH
Citation: Hr. Tang et al., Neuroblastoma imaging using a combined CT scanner-scintillation camera andI-131-MIBG, J NUCL MED, 42(2), 2001, pp. 237-247
Authors:
Matthay, KK
Panina, C
Huberty, J
Price, D
Glidden, DV
Tang, HR
Hawkins, RA
Veatch, J
Hasegawa, B
Citation: Kk. Matthay et al., Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma. treated with I-131-MIBG, J NUCL MED, 42(11), 2001, pp. 1713-1721
Authors:
Rudnick, E
Khakoo, Y
Antunes, NL
Seeger, RC
Brodeur, GM
Shimada, H
Gerbing, RB
Stram, DO
Matthay, KK
Citation: E. Rudnick et al., Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: Clinical outcome and antineuronal antibodies - A report from the Children's Cancer Group study, MED PED ONC, 36(6), 2001, pp. 612-622
Authors:
Cooper, R
Khakoo, Y
Matthay, KK
Lukens, JN
Seeger, RC
Stram, DO
Gerbing, RB
Nakagawa, A
Shimada, H
Citation: R. Cooper et al., Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: Histopathologic features - A report from the Children's Cancer Group, MED PED ONC, 36(6), 2001, pp. 623-629
Authors:
Maris, JM
Guo, C
White, PS
Hogarty, MD
Thompson, PM
Stram, DO
Gerbing, R
Matthay, KK
Seeger, RC
Brodeur, GM
Citation: Jm. Maris et al., Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma, MED PED ONC, 36(1), 2001, pp. 24-27
Authors:
Thompson, PM
Seifried, BA
Kyemba, SK
Jensen, SJ
Guo, C
Maris, JM
Brodeur, GM
Stram, DO
Seeger, RC
Gerbing, R
Matthay, KK
Matise, TC
White, PS
Citation: Pm. Thompson et al., Loss of heterozygosity for chromosome 14q in neuroblastoma, MED PED ONC, 36(1), 2001, pp. 28-31
Authors:
Maris, JM
Guo, C
Blake, D
White, PS
Hogarty, MD
Thompson, PM
Rajalingam, V
Gerbing, R
Stram, DO
Matthay, KK
Seeger, RC
Brodeur, GM
Citation: Jm. Maris et al., Comprehensive analysis of chromosome 1p deletions in neuroblastoma, MED PED ONC, 36(1), 2001, pp. 32-36
Authors:
Hayward, K
Jeremy, RJ
Jenkins, S
Barkovich, AJ
Gultekin, SH
Kramer, J
Crittenden, M
Matthay, KK
Citation: K. Hayward et al., Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: Relationship to MRI findings and anti-neuronal antibodies, J PEDIAT, 139(4), 2001, pp. 552-559
Authors:
Plantaz, D
Vandesompele, J
Van Roy, N
Lastowska, M
Bown, N
Combaret, V
Favrot, MC
Delattre, O
Michon, J
Benard, J
Hartmann, O
Nicholson, JC
Ross, FM
Brinkschmidt, C
Laureys, G
Caron, H
Matthay, KK
Feuerstein, BG
Speleman, F
Citation: D. Plantaz et al., Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11Q deletion in tumors lacking MYCN amplification, INT J CANC, 91(5), 2001, pp. 680-686
Authors:
Shimada, H
Umehara, S
Monobe, Y
Hachitanda, Y
Nakagawa, A
Goto, S
Gerbing, RB
Stram, DO
Lukens, JN
Matthay, KK
Citation: H. Shimada et al., International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors - A report from the Children's Cancer Group, CANCER, 92(9), 2001, pp. 2451-2461
Authors:
Uusitalo, MS
Van Quill, KR
Scott, IU
Matthay, KK
Murray, TG
O'Brien, JM
Citation: Ms. Uusitalo et al., Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination, ARCH OPHTH, 119(1), 2001, pp. 41-48
Authors:
Matthay, KK
Stram, D
Citation: Kk. Matthay et D. Stram, Is adjuvant therapy ever warranted in localized neuroblastoma, J PED H ONC, 22(5), 2000, pp. 399-402
Authors:
Antunes, NL
Khakoo, Y
Matthay, KK
Seeger, RC
Stram, DO
Gerstner, E
Abrey, LE
Dalmau, J
Citation: Nl. Antunes et al., Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus, J PED H ONC, 22(4), 2000, pp. 315-320
Authors:
Schatz, J
Kramer, JH
Ablin, A
Matthay, KK
Citation: J. Schatz et al., Processing speed, working memory, and IQ: A developmental model of cognitive deficits following cranial radiation therapy, NEUROPSYCHL, 14(2), 2000, pp. 189-200
Authors:
Maris, JM
Weiss, MJ
Guo, C
Gerbing, RB
Stram, DO
White, PS
Hogarty, MD
Sulman, EP
Thompson, PM
Lukens, JN
Matthay, KK
Seeger, RC
Brodeur, GM
Citation: Jm. Maris et al., Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: A Children's Cancer Group study, J CL ONCOL, 18(9), 2000, pp. 1888-1899
Authors:
Schmidt, ML
Lukens, JN
Seeger, RC
Brodeur, GM
Shimada, H
Gerbing, RB
Stram, DO
Perez, C
Haase, GM
Matthay, KK
Citation: Ml. Schmidt et al., Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study, J CL ONCOL, 18(6), 2000, pp. 1260-1268
Authors:
Nickerson, HJ
Matthay, KK
Seeger, RC
Brodeur, GM
Shimada, H
Perez, C
Atkinson, JB
Selch, M
Gerbing, RB
Stram, DO
Lukens, J
Citation: Hj. Nickerson et al., Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: A Children's Cancer Group study, J CL ONCOL, 18(3), 2000, pp. 477-486
Authors:
Seeger, RC
Reynolds, CP
Gallego, R
Stram, DO
Gerbing, RB
Matthay, KK
Citation: Rc. Seeger et al., Quantitative tumor cell content of bone marrow and blood as a predictor ofoutcome in stage IV neuroblastoma: A Children's Cancer Group Study, J CL ONCOL, 18(24), 2000, pp. 4067-4076
Authors:
Ozkaynak, MF
Sondel, PM
Krailo, MD
Gan, J
Javorsky, B
Reisfeld, RA
Matthay, KK
Reaman, GH
Seeger, RC
Citation: Mf. Ozkaynak et al., Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: A Children's Cancer Group Study, J CL ONCOL, 18(24), 2000, pp. 4077-4085
Authors:
Matthay, KK
Citation: Kk. Matthay, MYCN expression in neuroblastoma: A mixed message?, J CL ONCOL, 18(21), 2000, pp. 3591-3594
Authors:
Perez, CA
Matthay, KK
Atkinson, JB
Seeger, RC
Shimada, H
Haase, GM
Stram, DO
Gerbing, RB
Lukens, JN
Citation: Ca. Perez et al., Biologic variables in the outcome of stages I and II neuroblastoma treatedwith surgery as primary therapy: A children's cancer group study, J CL ONCOL, 18(1), 2000, pp. 18-26
Authors:
Haas-Kogan, DA
Fisch, BM
Wara, WM
Swift, PS
Farmer, DL
Harrison, MR
Albanese, C
Weinberg, V
Matthay, KK
Citation: Da. Haas-kogan et al., Intraoperative radiation therapy for high-risk pediatric neuroblastoma, INT J RAD O, 47(4), 2000, pp. 985-992
Authors:
Goto, H
Keshelava, N
Matthay, KK
Lukens, JN
Gerbing, RB
Stram, DO
Seeger, RC
Reynolds, CP
Citation: H. Goto et al., Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors, MED PED ONC, 35(6), 2000, pp. 619-622